| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.013 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |